LIWANLI Innovation Co., Ltd.

TWSE:3054 Voorraadrapport

Marktkapitalisatie: NT$1.8b

LIWANLI Innovation Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

LIWANLI Innovation has a total shareholder equity of NT$759.1M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$794.3M and NT$35.2M respectively.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

NT$0

Schuld

Rente dekkingsration/a
ContantNT$335.93m
AandelenNT$759.13m
Totaal verplichtingenNT$35.16m
Totaal activaNT$794.29m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

A Look At LIWANLI Innovation's (TPE:3054) Share Price Returns

Dec 15
A Look At LIWANLI Innovation's (TPE:3054) Share Price Returns

Analyse van de financiële positie

Kortlopende schulden: 3054's short term assets (NT$386.8M) exceed its short term liabilities (NT$30.9M).

Langlopende schulden: 3054's short term assets (NT$386.8M) exceed its long term liabilities (NT$4.3M).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 3054 is debt free.

Schuld verminderen: 3054 had no debt 5 years ago.

Schuldendekking: 3054 has no debt, therefore it does not need to be covered by operating cash flow.

Rentedekking: 3054 has no debt, therefore coverage of interest payments is not a concern.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y